|
Most clinical studies regarding cannabis use have centered on its primary phytocannabinoid constitutes, delta-9-tetrahydrocannabinol and cannabidiol. THC is classified as mood-altering with its psychoactive components; CBD has no significant mood altering effects. The lack of clinical research surrounding cannabis limits its use as an effective therapeutic option to patients.
|